SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genzyme Tissue Repair (GZTR) -- Ignore unavailable to you. Want to Upgrade?

To: lwd who wrote (2033)7/20/1998 5:37:00 PM
From: Bob Jagow  Respond to of 2553
 
Yes, their problems were covered in the BW cover article
businessweek.com
[by the writer that you [or your husband] found such fault with ;)] -- still a good read IMO.
Points out that many of the cos have cash infusions from drug partners; perhaps negating GENZL's perceived advantage.
Nothing wrong with spinoffs but GENZ is not a TMO.



To: lwd who wrote (2033)7/21/1998 3:17:00 PM
From: lwd  Respond to of 2553
 
To All: The quarterly report will be released after the market closes tomorrow. Same time also for the Quarterlies scheduled for Oct. 21st and Mar. 3rd. Per Genzyme.
Lisa


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News